Encompass Health (NYSE:EHC) Given New $140.00 Price Target at KeyCorp

Key Points

• KeyCorp has raised its target price for Encompass Health from $135.00 to $140.00, suggesting a potential upside of 12.34% from the current stock price, while maintaining an "overweight" rating.
• Encompass Health reported an EPS of $1.40 for its last quarter, exceeding analyst expectations of $1.20, with revenues of $1.46 billion representing a year-over-year increase of 12%.
• Despite recent analyst upgrades, Encompass Health's shares have traded down 1.1% as of the latest opening, reflecting market volatility amid generally positive performance metrics.

Encompass Health (NYSE:EHC - Get Free Report) had its target price hoisted by investment analysts at KeyCorp from $135.00 to $140.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an "overweight" rating on the stock. KeyCorp's price objective would indicate a potential upside of 12.34% from the stock's current price.

Several other analysts also recently commented on the stock. Truist Financial lifted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a report on Thursday, August 14th. UBS Group increased their target price on Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Bank of America raised their price objective on Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a research report on Wednesday, September 10th. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a report on Thursday, June 5th. Finally, Wall Street Zen downgraded Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. One equities research analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $138.43.

Encompass Health Trading Down 1.1%

Shares of NYSE:EHC opened at $124.62 on Tuesday. Encompass Health has a 12 month low of $87.85 and a 12 month high of $127.15. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The company's fifty day simple moving average is $117.61 and its 200 day simple moving average is $113.11. The firm has a market cap of $12.55 billion, a price-to-earnings ratio of 24.39, a PEG ratio of 2.20 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The company reported $1.40 EPS for the quarter, topping analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period last year, the business posted $1.11 earnings per share. The firm's quarterly revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, research analysts forecast that Encompass Health will post 4.8 EPS for the current fiscal year.

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 2.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Osaic Holdings Inc. boosted its position in shares of Encompass Health by 7.2% in the 2nd quarter. Osaic Holdings Inc. now owns 13,721 shares of the company's stock worth $1,682,000 after purchasing an additional 919 shares in the last quarter. Newbridge Financial Services Group Inc. lifted its holdings in Encompass Health by 112.5% in the second quarter. Newbridge Financial Services Group Inc. now owns 425 shares of the company's stock valued at $52,000 after acquiring an additional 225 shares during the last quarter. FORA Capital LLC acquired a new position in Encompass Health during the second quarter worth $1,640,000. Evergreen Capital Management LLC purchased a new stake in shares of Encompass Health during the second quarter worth $239,000. Finally, Headlands Technologies LLC increased its holdings in Encompass Health by 5,474.1% in the second quarter. Headlands Technologies LLC now owns 1,505 shares of the company's stock valued at $185,000 after buying an additional 1,478 shares during the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.